Date:8/9/2011

eptive Informatics, Inc. (PII)Service revenue$
42,462$
38,348% of total service revenue13.7%13.0%Gross profit$
8,226$
7,751Gross margin % of service revenue42.9%46.3%Total service revenue$
310,524$
295,301Total gross profit$
,654$
,531Gross margin % of service revenue32.4%37.4%Revenue by GeographyThe Americas$
7,576$
23,871Europe, Middle East & Africa146,063134,603Asia/Pacific46,88536,827Total service revenue$
310,524$
295,301Quarterly Supplemental Financial DataTotal revenue$
363,157$
345,951Investigator fees52,07954,590Gross revenue$
415,236$
400,541Days sales outstanding6949Capital expenditures21,42630,436(a) Prior year numbers have been reclassified to conform with the current year presentation.PAREXEL International CorporationSegment InformationUnauditedTwelve Months EndedTwelve Months Ended(in thousands)June 30, 2011June 30, 2010 (a)As ReportedAdjustmentsNon-GAAPAs ReportedClinical Research Services (CRS)Service revenue $
922,827$
922,827$
870,721% of total service revenue76.1%76.1%77.0%Gross profit$
306,150201

(b)

$
306,351$
307,937Gross margin % of service revenue33.2%33.2%35.4%PAREXEL Consulting & Medical Communications  Services (PCMS)Service revenue$
29,728$
29,728$
21,652% of total service revenue10.7%10.7%10.8%Gross profit$
52,04955

(b)

$
52,104$
46,386Gross margin % of service revenue40.1%40.2%38.1%Perceptive Informatics, Inc. (PII)Service revenue$
59,544$
59,544$
38,666% of total service revenue13.2%13.2%12.2%Gross profit$
8,066112

(b)

$
8,178$
57,872Gross margin % of service revenue42.7%42.7%41.7%Total service revenue$   1,212,099$ 1,212,099$   1,131,039Total gross profit$
426,265368$
426,633$
412,195Gross margin % of service revenue35.2%35.2%36.4%Revenue by GeographyThe Americas$
484,657$
484,657$
449,357Europe, Middle East & Africa553,801553,801548,412Asia
'/>"/>

SOURCE PAREXEL International Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13
Related medicine technology :

1. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2011 Earnings Release and Conference Call
3. PAREXEL International to Present at Goldman Sachs Healthcare Conference and Jefferies Global Healthcare Conference
4. PAREXEL Invites Public to Listen to Live Webcast of Its Investor Day June 2, 2011
5. PAREXEL Reports Third Quarter Fiscal Year 2011 Financial Results
6. Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
7. PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market
8. PAREXEL Announces Date of Third Quarter Fiscal Year 2011 Earnings Release and Conference Call
9. PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
10. PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting
11. PAREXEL International to Present at Raymond James Investors Conference